Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Inovio Pharmaceuticals has reported a net loss attributable to the company of $6.62m, or $0.05 per share, for the third quarter ended 30 September 2012 compared to a net loss attributable to the company of $4.54m, or $0.04 per share, for the third quarter ended 30 September 2011.
Subscribe to our email newsletter
Total revenues for third quarter of 2012 were $854,696 compared to $2.64m for the third quarter of 2011.
The company reported a net loss attributable to the company of $19.01m, or $0.14 per share, for the nine months ended 30 September 2012 compared to a net loss attributable to the company of $9.78m, or $0.08 per share, for the nine months ended 30 September 2011.
Total revenue of $2.98m was reported for the first nine months of 2012 compared to $8.16m for the first nine months of 2011.